Hepatic mTORC2 activates glycolysis and lipogenesis via Akt, glucokinase, and SREBP1c - Evidence review
Mouse liver studies show mTORC2, via Akt, glucokinase and SREBP1c, supports glycolysis, lipogenesis and glucose suppression; human evidence is limited.
Authors
- Antonio Conte (ORCID: https://orcid.org/0009-0001-3718-6780)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24340774
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00